Emoritcha, Antonio V.

HRN: 11-81-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/09/2025
06/15/2025
IVTT
4.5g
Q8
Cap HR
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: